You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Dog cloning auctions, BioNumbers, GenePattern updates, a poetic gene, and gene-splicing humor.
Plant-based biofuels will be a tough row to hoe no matter how you look at it, NYT reports.
Massachusetts prepares its life sciences bill, complete with earmarks.
SF Chronicle covers the latest Ernst & Young biotech report. Some good news, some bad.
Duke's Homme Hellinga retracted two journal articles and sparked an investigation as well as a discussion.
Researchers use E. coli as a 'computer.'
Scientists bring extinct Tasmanian tiger DNA back to life.
A review article and a blogger examine genome-wide association studies.
A survey looks at how high school biology teachers treat evolution and creationism in the classroom and offers reasons why.
Researchers use computational analysis to study HIV infection.
Google Health is live.
An article describes next-gen newcomer ZS Genetics' sequencing technology.
Agricultural genetics research is still being cut, says the New York Times.
A blogger warns about press hype concerning two hot fields.
Researchers have developed transgenic monkeys to study Huntington's disease.
Bloggers discuss an editorial from last week's Science.
Doctors start using gene expression chips in the ICU.
Scientists Without Borders launches.
MarketWatch interviews Drew Fromkin, CEO of Clinical Data.
This week's issue of Science takes a look at funding, a new proteome map, and more.
Personalized medicine officially takes flight for colon cancer.
A blogger describes his experience judging students' projects in his machine-learning class.
As fewer patients enroll in clinical trials, medical centers and other groups are trying new tactics to lure them in.
A paper compares mutant yeast to cancer cells.
The FDA commissioner officially asks Congress for more money.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.